Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Phyllanthus niruri extract is a herbal preparation derived from the Phyllanthus niruri plant, traditionally used in Ayurvedic, Chinese, and Malay medicine. The extract contains bioactive compounds such as lignans (e.g., phyllanthine and hypophyllanthine), alkaloids, and flavonoids (e.g., quercetin). It has demonstrated hepatoprotective, antiviral (notably against hepatitis B virus by blocking DNA polymerase), antibacterial, hypolipidemic, hypoglycemic, analgesic, anti-inflammatory, cardioprotective, anti-urolithiatic (kidney stone prevention), and antihyperuricemic properties in preclinical studies. Clinical trials have shown mixed results for chronic hepatitis B treatment. The primary indications are liver disorders and antiviral therapy; it is also used for kidney stones and urinary tract health[1][2][3][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on phyllanthus niruri extract.